Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Eighty percent of medications that receive accelerated approval don’t extend overall survival.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
Four out of 10 FDA workers are sidelined.
Did you know there’s a preventive vaccine for the world’s most common STI?
Human papillomavirus vaccine can prevent cervical, anal and oral cancers.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
Lucemyra is approved to treat the symptoms of opioid withdrawal for 14 days.
The FDA commissioner wants drugmakers to “end the shenanigans.”
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Mike Sauers works for the U.S. Food and Drug Administration, and is one of more than 79,000 individuals who make HHS run every day.
Two targeted therapies, Tafinlar and Mekinist, for non-small-cell lung cancer with a specific BRAF mutation have been approved.
Scott Gottlieb has said he wants lower costs and faster drug approvals.
Radicava, given intravenously, is the first new treatment for the deadly neurological disease in more than two decades.
The agency is tasked with making sure our food and drugs are safe.
He also told pharma leaders: “We have to get prices down. We have no choice.”
Obama signs the biggest health legislation since his Affordable Care Act. What strings are attached?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.